Thematische Bibliographien / Oncology center

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen
Bücher
Buchteile
Konferenzberichte
Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Oncology center“

Autor: Grafiati

Veröffentlicht am 28. Juni 2021

Zuletzt aktualisiert am 11. Februar 2022

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Oncology center" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Oncology center"

Geiser, Clare. „Oncology at Center Stage“. Oncology Issues 14, Nr. 4 (Juli 1999): 40. http://dx.doi.org/10.1080/10463356.1999.11904859.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cherney, Alison. „Marketing Your Radiation Oncology Center“. Oncology Issues 20, Nr. 2 (März 2005): 30–31. http://dx.doi.org/10.1080/10463356.2005.11883246.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bosch, Xavier. „Spanish oncology center under threat“. Nature Medicine 6, Nr. 8 (August 2000): 847. http://dx.doi.org/10.1038/78590.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cira, M., R. Abudu, D. Pyle, S. Akhavan und K. Duncan. „A Snapshot of Global Oncology Programming at US Cancer Centers: Results of the 2018 US NCI/ASCO NCI-Designated Cancer Center Global Oncology Survey“. Journal of Global Oncology 4, Supplement 2 (01.10.2018): 220s. http://dx.doi.org/10.1200/jgo.18.89200.

Der volle Inhalt der Quelle

Annotation:

Background: The US National Cancer Institute (NCI) Center for Global Health (CGH) serves as a clearinghouse of information on global oncology activities within the NCI and across the 70 NCI-designated Cancer Centers. Global oncology, as defined by the American Society of Clinical Oncology (ASCO), “addresses disparities and differences in cancer prevention, care, research, education and the disease's social and human impact around the world”. While CGH routinely reports on NCI-funded global oncology projects conducted at the cancer centers, there is limited reporting of non-NCI funded global oncology activities of the cancer centers. To address this gap, CGH has surveyed the cancer centers about their global oncology programs and projects informally in 2012 and 2014. The 2018 survey, in partnership with ASCO, represents the first systematically conducted survey, with new questions about cancer center global oncology programs, faculty, and trainees. Aim: The aim of the 2018 survey is to develop a summary report of cancer center global oncology programs for use by cancer centers as a knowledge sharing and collaborative tool; by the NCI to inform program development; and, by ASCO to better understand the current state of global oncology training at US institutions. Methods: CGH developed a 2-part online survey with questions about global oncology projects led by cancer centers, and the level of support for global oncology training and faculty engagement at cancer centers. CGH piloted the survey to 7 of the 70 cancer centers (10%) from January to March 2018. Revisions based on the pilot were made, and CGH fielded the survey to the rest of the 63 cancer centers (90%) from March to July 2018. CGH supplemented the survey data with an Internet search of cancer centers' Web sites. The submitted data will be compiled, analyzed, and organized into a summary report for distribution to NCI, ASCO, and the cancer centers. Results: Data from the 7 pilot institutions show that while all 7 institutions (100%) have a global oncology program, there is great variance in the percentage of global oncology faculty who receive external or administrative research grant support for their work. Three institutions (43%) report that 50% or fewer global oncology faculty receive external research grant support, and 6 institutions (86%) report that 50% or fewer global oncology faculty receive cancer center administrative fund support for their work. Additional results and analysis will be available and presented as part of this presentation. Conclusion: In addition to serving as a knowledge sharing and collaboration tool for cancer centers, the global oncology survey allows NCI, ASCO, and global oncology partners to understand the current landscape of and sources of support for global oncology training, research, and programming at the cancer centers. This information will inform future discussions on how to strengthen global oncology programming and partnerships.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Albritton, Karen H., Charles H. Wiggins, Harold E. Nelson und Jane C. Weeks. „Site of Oncologic Specialty Care for Older Adolescents in Utah“. Journal of Clinical Oncology 25, Nr. 29 (10.10.2007): 4616–21. http://dx.doi.org/10.1200/jco.2006.08.4103.

Der volle Inhalt der Quelle

Annotation:

Purpose Adolescents with cancer may access oncologic care from pediatric or adult medical centers, given overlapping age eligibility. However, some recent data suggest a benefit to adolescents with certain cancers when treated at pediatric centers or on pediatric protocols. We used a population-based registry to determine the site of care of children, adolescents, and young adults (age 0 to 24 years) with newly diagnosed cancer. Patients and Methods From the Utah Cancer Registry 1994 to 2000, new malignant cases in patients aged 0 to 24 years were chosen; data including diagnosis, home ZIP code and sites of oncologic care were abstracted. Distance between home ZIP code and Primary Children's Medical Center (PCMC; Salt Lake City, Utah), the state's sole site of pediatric oncology care, was determined. Results Sixty-six percent of Utah 15- to 19-year-olds with cancer were never seen by a PCMC oncologist. Even among this narrow age range, utilization of the pediatric center dropped with each additional year of age. Not unexpectedly, few of those with epithelial malignancies in this age group were seen at PCMC. But surprisingly, 47% of the older adolescents with leukemia, 66% with brain tumors, and 71% with lymphoma never saw a pediatric oncologist. After consideration of age and diagnosis, distance the patient lived from PCMC had a negligible effect on the likelihood of an adolescent being seen there. Conclusion The referral of adolescents with cancer to a pediatric oncology center diminishes greatly with age, and is moderately influenced by diagnosis and minimally by distance from center. Further study should investigate reasons for referral patterns, and impact on outcomes.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Steen, M. Willemijn, Claire van Vliet, Sebastiaan Festen, Marc G. Besselink, Michael F. Gerhards und Olivier R. Busch. „Regional oncology network between pancreatic centers safeguards waiting times for pancreatoduodenectomy“. Updates in Surgery 71, Nr. 4 (10.09.2019): 645–51. http://dx.doi.org/10.1007/s13304-019-00677-6.

Der volle Inhalt der Quelle

Annotation:

Abstract Pancreatoduodenectomy (PD) is increasingly performed in high-volume centers, which may compromise waiting times. The aim of this study was to evaluate patient flow and outcome of PD within a regional oncology network of two high-volume centers. A post hoc analysis of a partially retrospective and prospective database was performed of all patients who underwent PD for pancreatic or periampullary neoplasms in both centers of the Gastrointestinal Oncology Center Amsterdam, a collaboration between an academic center and affiliated general teaching hospital, from 2010 to 2014. Outcomes included waiting time to surgery and postoperative morbidity and mortality. A total of 525 PDs were performed, 329 in the academic center (annual volume 66) and 196 in the teaching hospital (annual volume 39). Neoadjuvant treatment was more often used in the academic center, other baseline characteristics were similar. Overall time to surgery was 26 days, which was significantly less in the teaching hospital. The major postoperative morbidity rate was 38.3% (n = 201), and the 30- and 90-day mortality was 2.3% and 3.6%. A regional oncology network between an academic center and a general teaching hospital for PD can be an attractive option to safeguard waiting times in selected patients, without compromising outcome.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Rieger, Paula Trahan. „Bringing oncology nursing front and center“. Nursing Outlook 48, Nr. 5 (September 2000): 241. http://dx.doi.org/10.1016/s0029-6554(00)70024-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Adderson, Elisabeth E. „Histoplasmosis in a pediatric oncology center“. Journal of Pediatrics 144, Nr. 1 (Januar 2004): 100–106. http://dx.doi.org/10.1016/j.jpeds.2003.10.035.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Fink, Jennifer L. W. „FDA launches Oncology Center of Excellence“. Cancer 122, Nr. 22 (07.11.2016): 3421–22. http://dx.doi.org/10.1002/cncr.30407.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Prigoff, Jake, Grace Hillyer, Fletcher Bell und Melissa Kate Accordino. „Effects of COVID-19 on an academic breast oncology center in New York City.“ Journal of Clinical Oncology 38, Nr. 29_suppl (10.10.2020): 51. http://dx.doi.org/10.1200/jco.2020.38.29_suppl.51.

Der volle Inhalt der Quelle

Annotation:

51 Background: The influx of patients to the healthcare system due to COVID-19 impacted healthcare practices including the care of breast cancer patients. Our aim is to describe the impact this pandemic had on breast cancer care delivery at an academic center in NYC to inform policy and procedure for future crises that limit patient access to on-site facilities. Methods: A survey was sent to physicians involved in the care of patients with breast cancer at Columbia University Irving Medical Center in May 2020. Participants were asked about practice structure and changes to breast cancer care. The primary outcome was the degree that providers believed breast oncology patients’ clinical outcomes were significantly impacted by COVID-19. Secondary outcomes included changes in diagnostic and management approaches and advice for future providers faced with a similar pandemic. Results: The response rate was 65.4% (17/26). This included physicians from medical oncology (n = 7), radiology (n = 4), breast surgery (n = 3), radiation oncology (n = 2), and plastic surgery (n = 1). Seventy-six percent of physicians somewhat agreed, agreed, or strongly agreed that oncologic outcomes may be significantly impacted by the COVID-19 pandemic. Nearly half (47%) of respondents reported delays in the workup of patients due to COVID-19 with 50.0% for mammograms, 47.5% for bone scans, 46.0% for ultrasounds, 43.8% for PET scans, and 43.3% for biopsies. Eighty-two percent reported delays in overall oncologic management. Delays to systemic therapy were: intravenous/targeted therapy (37.9%), intramuscular/subcutaneous endocrine therapy (28.3%), oral chemotherapy/targeted therapy (22.9%), and oral endocrine therapy (12.8%). Delays to local therapy were: surgery (64.4%) and radiation therapy (44.6%). Almost two-thirds (64.7%) reported it necessary to use alternative oncologic management strategies. The most common piece of advice our providers offered was to increase testing capacity to all patients, especially when coming to a healthcare facility. Conclusions: The COVID-19 pandemic has caused major disruption to breast cancer practices. Breast oncology physicians reported delays in management in over 80% of patients, and the need to use alternative management strategies in over 60% of patients. Effects of these disruptions on oncologic outcomes are unknown, but over 75% of our physicians believe this will significantly impact breast oncology patients’ outcomes. There's a need for policies and procedures to structure patient care should there be a future crisis that limits patient access to oncologic care.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Oncology center"

Gokul, Sheila R. „Identifying Barriers to Enrollment and Strategies to Increase Enrollment at a Community-Based Cancer Treatment Center“. Thesis, University of North Texas Health Science Center at Fort Worth, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=1556271.

Der volle Inhalt der Quelle

Annotation:

Although clinical trials are essential for the development of cancer treatments, only approximately 3% of cancer patients in the U.S. participate in them. While 55% of these patients are enrolled in cancer clinical trials through community-based practices and around 80% of all cancer patients are seen at this type of practice, there is a lack of knowledge about the enrollment barriers at these sites. This study evaluates enrollment barriers at a community-based cancer clinic at the levels of the investigative site, healthcare provider, and patient. Barriers to enrollment and strategies to increase enrollment are evaluated through historical data analyses and results from a survey assessing the opinions of healthcare providers on enrollment and research practices.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lawson, Scott. „The Urban Therapeutic Environment: A Cancer Treatment and Rehabilitation Center in Corryville, Ohio“. University of Cincinnati / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1337265353.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Marusak, Charles. „MT1-MMP: TARGETING THE CENTER OF MELANOMA METASTASIS, GROWTH AND TREATMENT RESISTANCE“. Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1548327646756039.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Fernandes, David Manuel Agostinho de Sousa. „Projetar com cor, cor e matéria“. Master's thesis, Universidade de Lisboa, Faculdade de Arquitetura, 2019. http://hdl.handle.net/10400.5/19088.

Der volle Inhalt der Quelle

Annotation:

Dissertação de Mestrado Integrado em Arquitetura, com a especialização em Interiores e Reabilitação do Edificado apresentada na Faculdade de Arquitetura da Universidade de Lisboa para obtenção do grau de Mestre.
presente Projeto Final de Mestrado tem como objetivo a proposta arquitetónica de um equipamento de saúde, através da aplicação dos conceitos da Luz, da Cor e da Matéria, que se revelam como os principais métodos e ferramentas, para o desenvolvimento e conceção desta proposta que se situa na freguesia de Marvila, em Lisboa. Situada na zona oriental da cidade de Lisboa, Marvila revela um passado com imensos marcos históricos e com um cariz industrial que ainda permanece. Esta zona encontra-se fragmentada e descaracterizada por consequência da desativação industrial e, por essa razão existem diversos problemas que necessitam de ser resolvidos. Ainda assim evidencia diversos pontos de interesse com imensos benefícios, e por meio da sua requalificação urbana, Marvila retorna a integrar-se na cidade de Lisboa. Com a inserção do Equipamento de Saúde, que tem como objetivo servir a população residente e não residente, irá conceder-se uma nova vida ao local, com a promoção e o rejuvenescimento de Marvila. Irá então atrair novas pessoas à freguesia, impulsionando uma diversidade, como a integração, uma interação e convivência social, que outrora existia em Marvila. O Projeto Final de Mestrado encontra-se estruturado por duas componentes de trabalho, sendo a primeira componente a teórica e a segunda componente a prática. Na componente teórica não só foram desenvolvidos os conceitos de Luz, Cor e Matéria, como também o de Arquitetura para Espaços de Saúde. Esses conceitos revelaram-se cruciais para adquirir os conhecimentos sobre estes temas, de maneira a que no processo de elaboração do projeto este se apresente como funcional, lógico e concebível. Relativamente à componente prática, foram exercidos diversos estudos de vários espaços de saúde, seguindo todo o desenvolvimento do equipamento de saúde e quais as soluções ideais, bem como quais as estratégias de luz, cor e matéria que foram implementadas, chegando-se assim à melhor solução de projeto. De seguida, foi realizada uma análise e investigação sobre a freguesia de Marvila, finalizando-se com uma descrição sobre o projeto e todo o processo de trabalho para a conceção do mesmo.
ABSTRACT: This Master’s Final Project has as purpose an architectural proposal of a health equipment through application of the concepts Light, Colour and Matter that turns out to be the main methods and tools for the development and conception of this proposal which is located in the parish of Marvila, in Lisbon. Situated in the eastern area of the city of Lisbon, Marvila has a past filled with great historical landmarks and it still has industrial features. This area is divided and uncharacterized as a consequence of the industrial deactivation and for that reason there are several problems that need to be solved. Even so, it still shows several points of interest with a lot of benefits, and through its urban requalification Marvila returns to be integrated in the city of Lisbon. With the implementation of a health care equipment, which is intended to serve the resident and non-resident population, it will represent a fresh life to the parish with the promotion and rejuvenation of Marvila. It will also attract new people to the place, creating a new diversity as integration, interaction and social living, aspects that used to exist in Marvila. The Final Master Project is structured in two components. The first one is the theoretical component and the second one represents the practical component. In the theoretical component, not only were the concepts of Light, Colour and Matter developed, but also those of Architecture for Health Spaces. These concepts proved to be crucial for acquiring knowledge about these themes, so that in the process of designing the project this is presented as functional, logical and conceivable. Regarding the practical component, were studied several cases of different health care facilities, following the development of the health equipment and the ideal solutions, as well which strategies of Light, Colour and Matter that were implemented, achieving through that way the best project solution. The following step was the execution of an analysis and a research about the parish of Marvila, ending with a description about the project and all the work process for the conception of the same.
N/A

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bitsko, Matthew John. „Psychosocial Adjustment of Adolescent Cancer Survivors: Time Perspective and Positive Emotions as Mediators to Quality of Life and Benefit Finding“. VCU Scholars Compass, 2005. http://scholarscompass.vcu.edu/etd/673.

Der volle Inhalt der Quelle

Annotation:

Adolescents with cancer are surviving at improved rates with levels of psychopathology in line with their healthy peers. Thus, recent psycho-oncology research is focusing on finding significant predictors to their positive adjustment and psychosocial functioning. The author examined adolescent cancer survivors (n = 50; diagnosis age = 10 21; 2 10 years post-diagnosis) to test the mediation effects of positive emotionns (satisfaction with life, subjective happiness, and optimism) and time perspective on the outcome variables quality of life and benefit finding with demographic/medical variables (gender, number of treatments received for cancer, and previous psychotherapy) as independent variables. Results indicated that positive emotions fully mediated the relationship between the number of treatments received for cancer and quality of life and partially mediated the relationship between having engaged in psychotherapy and quality of life with adolescent cancer survivors. Importantly, results indicated that patients' with a relapse diagnosis scored significantly different than those with no relapse diagnosis on quality of life. Although positive emotions were significantly associated with scores on benefit finding in a positive direction, benefit finding did not fit two of the four criteria for mediation. Time perspective indices did not meet full criteria for significant mediation with the relationships between independent and outcome variables. Regarding time perspective indices, significant associations included: prior participating in psychotherapy was associated with higher scores on a Past-Negative time perspective, the more treatments received for cancer was associated with higher scores on a Present-Focused time perspective, and higher scores on the Past-Negative time perspective was associated with lower scores on benefit finding. Discussion centers on the use of evidence-based interventions that cultivate positive emotions with adolescent cancer survivors and the utility of implementing quality of life assessment in pediatric medical settings. Continued emphasis is placed on larger sample sizes via multi-center cooperation that may better illustrate adjustment difficulties within subgroups of this population (i.e. relapse diagnosis). Future research considerations are provided for the constructs of time perspective and benefit finding.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Thompson, Eloine Caroline. „Environments that heal : an oncology centre at mediclinic midstream, South Africa“. Diss., University of Pretoria, 2016. http://hdl.handle.net/2263/60212.

Der volle Inhalt der Quelle

Annotation:

This study focuses on creating optimal healing environments. It uses the healthcare sector as the vehicle for design, research and understanding of the negative experiences associated with healthcare environments. There is an untapped potential for these spaces to become not only curative but also spaces of healing. This provides an opportunity to conduct a critical assessment of what optimal healing environments are and the translation thereof to tangible and meaningful design. This is done through the implementation of evidence-based theories made visible through design. This transformation takes form from the concept of skin as a regenerative healing and protective organ - a comparison is drawn to buildings and their ability to perform and protect. Spaces are identified as consisting of interdependent elements and layers, which, in this study, are referred to as "enablers". These enable a designer to create spatial literacy, which is fundamental in transforming information into visible design. Ultimately, spaces can then become catalysts for healing through layers of intervention. The design outcome of the theoretical investigation is a design proposal for an Oncology Centre in the future extension of Mediclinic Midstream. The proposed design aims to reinvigorate the senses of cancer patients burdened by the emotional, biological and physiological typical of appointments at various medical practitioners, chemotherapy sessions and operating rooms. The intention is to be a reflect a movement in the field of interior design, which endeavours to shift the perception of healing in the medical sector. It encapsulates the natural and structural elements of design in an environment that stimulate the senses - imitating the ever-regenerating skin cells of the human body. Proving that that interior design should play an active and critical role the healthcare sector.
Hierdie studie fokus op die skep van optimale gesondheidsorg omgewings. Dit maak gebruik van die gesondheidssektor as die voertuig vir ontwerp, navorsing en begrip van die negatiewe ervarings wat verband hou met gesondheidsorg omgewings. Daar is 'n onontginde potensiaal vir hierdie ruimtes om nie net fisiese genesing maar ook ruimtes van emosionele genesing te word. Dit bied 'n geleentheid om 'n kritiese evaluering van wat optimale genesing omgewings is en die vertaling daarvan na tasbare en sinvolle ontwerp uit te voer. Dit word gedoen deur middel van die implementering van bewysgebaseerde teorie?, sigbaar gemaak deur ontwerp. Hierdie transformasie neem vorm binne die konsep van die vel as 'n regeneratiewe genesing en beskermende orgaan - 'n vergelyking word gevestig op geboue en hul vermo? van diensbaarheid en beskerming. Spasies word ge?dentifiseer as bestaande interafhanklike elemente en lae, wat in hierdie studie, verwys word as 'enablers'. Hierdie stel 'n ontwerper in staat om ruimtelike atmosveer te ontwerp, wat fundamenteel is in die transformasie van inligting in sigbare ontwerp. Uiteindelik, kan spasies dan katalisators word vir genesing deur lae van ingryping. Die studie neem vorm in die ontwerp van 'n onkologie-sentrum in die toekomstige uitbreiding van Mediclinic Midstream. Dit is ontwerp om die sintuie van pasi?nte gebuk onder die emosionele, biologiese en fisiologiese gebondenheid van die hospitaal afsprake, chemoterapie sessies en die operasie kamer te versterk. Die verhandeling is 'n weerspie?ling van 'n ontwerp proses wat daarop gemik is vir die verskuiwing van die persepsie van genesing in die mediese sektor. Dit omvat die natuurlike en strukturele elemente van ontwerp in 'n omgewing wat die sintuie stimuleer - boots die immer-groeiende vel selle van die menslike liggaam na. Hierdie ontwerp is in teenstelling met die meer steriele omgewing van die aangrensende hospitaal. Die doel is om uiteindelik 'n ontwerp te skep, wat die rol wat ontwerp kan speel in die gesondheids sector, te bewys.
Mini Dissertation (MInt (Prof))--University of Pretoria, 2016.
Architecture
MInt (Prof)
Unrestricted

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Riches, John Charles. „The defects underlying impaired T-cell immunity in chronic lymphocytic leukaemia : the impact of lenalidomide“. Thesis, Queen Mary, University of London, 2013. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8446.

Der volle Inhalt der Quelle

Annotation:

CLL T cells exhibit functional defects and alterations in gene expression that show similarities to exhausted T cells in chronic viral infections. It is unclear whether CLL T cells are truly exhausted, or whether these defects are restricted to expanded populations of CMV specific cells. The phenotype and function of T cells from CLL patients was compared to age- and CMV-serostatus-matched controls. There were an increased proportion of effector T cells in CLL patients and CMV-seropositive individuals. CD8+ and CD4+ T cells from CLL patients had increased expression of exhaustion markers CD160 and CD244 irrespective of CMV-serostatus, whereas increased PD1 expression on CD8+ T cells was limited to CMV-seronegative patients. CLL CD8+ T cells also showed defects in proliferation and cytotoxicity irrespective of CMV-serostatus, with the cytolytic defect caused by impaired granzyme packaging into vesicles and non-polarized degranulation. In contrast to virally-induced exhaustion, CLL T cells had increased expression of TBET and increased interferon-γ production, but normal IL-2 production. As lenalidomide repairs the functional and phenotypic defects associated with T-cell exhaustion, the effect of this agent on the gene expression profiles of lymphocyte subsets from CLL patients and healthy controls was investigated. Lenalidomide induced the expression of genes involved in cytoskeletal signalling, lymphocyte activation, and proliferation. In particular, lenalidomide up-regulated the expression of several genes involved in tight junction signalling, a pathway that is potentially involved in lymphocyte motility, immune synapse formation, and transendothelial migration. This pathway was down-regulated in T cells from CLL patients, but, intriguingly, was up-regulated in CLL cells compared with healthy B cells. This pathway is known to be negatively regulated by a phosphatase, PP2A. Treatment of CLL cells and T cells with the PP2A inhibitor okadaic acid mimicked the effect of lenalidomide. In conclusion, CLL T cells exhibit features of pseudo-exhaustion irrespective of CMV serostatus. Lenalidomide up-regulates tight junction signalling, which is down-regulated in CLL T cells. Inhibition of PP2A is implicated in the mechanism of action of lenalidomide on T cells.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ribeiro, Coutinho Rita. „Exploring biomarkers from the tumour and the microenvironment in Diffuse Large B-cell Lymphoma“. Thesis, Queen Mary, University of London, 2014. http://qmro.qmul.ac.uk/xmlui/handle/123456789/9108.

Der volle Inhalt der Quelle

Annotation:

In the last decade unprecedented improvement in cure rates and overall survival was achieved in diffuse large B-cell Lymphoma (DLBCL) through the introduction of rituximab and anthracyclin-based chemotherapy (R-CHOP) as first line treatment. However, 40% of patients are refractory or relapse after R-CHOP and are hardly salvaged. To date, only age, International Prognostic Index (IPI) stratification and genetic aberrations defining gray-zone lymphomas have been used in clinical trials to select high-risk patients for more aggressive regimens. However, these prognostic features do not take into account the full biological heterogeneity of DLBCL. This reflects our limited knowledge on comprehensive prognostication in this group of disorders and supports our choice to investigate old and new prognostic factors for DLBCL in this thesis. Molecular characterization is generating opportunities for personalized therapy in poor-risk DLBCL. In order for targeted therapies to succeed in this disease, reliable and reproducible strategies that adequately segregate patients into distinct molecular groups are needed. While gene expression profiling (GEP) is the gold standard method, there is presently a lack of standardized methodology for array analysis, which can lead to variable results. The lack of a routine methodology for GEP has led investigators to develop immunohistochemistry (IHC) based approaches for the molecular classification in DLBCL. In fact, the Hans algorithm is being used to identify non-GCB DLBCLs in clinical trials offering NF-kB targeting agents to patients with this subtype. By performing a systematic comparison of nine IHC algorithms for molecular classification in a new large dataset of diagnostic DLBCL, we document an extremely low concordance across all classifiers (<21%) when classifying each individual patient, and a lack of outcome impact of all strategies, demonstrating that IHC is not a reliable alternative to molecular-based methods to be used for clinical decisions in DLBCL. GEP studies also suggested that the microenvironment could provide prognostic biomarkers in DLBCL in the R-CHOP era. Most authors have focused on the use of IHC to enumerate and functionally characterize the microenvironment in DLBCL. In our second study, by comparing two methods of semi-automated analysis for IHC staining Abstract 6 of the microenvironment, we demonstrate that the computerized results are highly reproducible, add the required robustness to IHC studies and should be used in the future instead of manual analysis. By applying comprehensive statistical analysis we propose that CD3 and FoxP3 should be validated as predictors of response to R-CHOP in clinical trials. Whereas a number of mechanisms by which cancer cells influence macrophage function have been described, currently there is very limited understanding of the macrophage polarisation status and effector function in human DLBCL. In our third study we analysed the GEP of macrophages sorted from human DLBCL samples. Unsupervised hierarchical clustering does not resolve DLBCL macrophage samples from reactive macrophage samples, indicating that macrophage heterogeneity in DLBCL should be considered. 202 genes are differentially expressed in DLBCL relative to controls. Functional annotation supports that these genes are macrophage-specific. We demonstrate that DLBCL macrophages have a bidirectional M1 and M2 functional activation, challenging the concept, widespread in the literature, that macrophages in tumours have a predominant M2 transcriptome. In our fifth study we used a two-cell co-culture model in an attempt to demonstrate that DLBCL cells influence macrophage transcriptome and proteome. The heterogeneity of the results, which precludes the confirmation of our hypothesis, is fully discussed. In our last study we tease out the DLBCL macrophage GEP heterogeneity and propose IFN- as a culprit B-cell derived molecule influencing macrophage activation status. Finally, using immunofluorescence we demonstrate that both M1 and M2 proteins are expressed in DLBCL macrophages.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Possari, João Francisco. „Dimensionamento de profissionais de enfermagem em centro cirúrgico especializado em oncologia: análise dos indicadores intervenientes“. Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/7/7140/tde-10052011-122056/.

Der volle Inhalt der Quelle

Annotation:

Com a finalidade de analisar os indicadores intervenientes do dimensionamento de profissionais de enfermagem, para assistência no período transoperatório do Centro Cirúrgico (CC), especializado em oncologia, foi realizada esta investigação de abordagem quantitativa, tipo estudo de caso, observacional, transversal e descritiva. A metodologia empregada compreendeu: identificação das atividades, por meio do registro no prontuário e da observação das atividades executadas pela equipe de enfermagem; mapeamento das atividades em linguagem padronizada de intervenções de enfermagem, segundo a Nursing Interventions Classification (NIC); validação das intervenções/atividades de enfermagem, utilizando a técnica de oficina de trabalho; mensuração do tempo despendido nas intervenções/atividades de enfermagem, adotando-se a técnica de amostragem do trabalho e identificação dos indicadores para o cálculo de profissionais de enfermagem. Foram identificadas e validadas 49 intervenções de enfermagem, sete domínios e 20 classes, segundo a taxonomia da NIC. Obteve-se 4831 mensurações de intervenções/atividades realizadas pela equipe de enfermagem, no transoperatório do CC. Os profissionais despenderam: enfermeiros 42,79% do seu tempo em intervenções de cuidados diretos e 42,00% em indiretos, 8,00% em atividades pessoais e 7,21% em associadas ao trabalho; técnicos de enfermagem (Circulação de Sala de Operação - CSO) 64,27% em intervenções de cuidados diretos e 30,46% em indiretos, 0,45% em atividades associadas e 4,82% em pessoais; técnicos de enfermagem (Instrumentação Cirúrgica - IC) 94,85% em intervenções de cuidados diretos e 2,20% em indiretos e 2,95% em atividades pessoais; técnicos de enfermagem (Recepção de Pacientes - RP) 57,08% em intervenções de cuidados diretos e 28,75% em indiretos, 7,92% em atividades associadas e 6,25% em pessoais e a equipe de enfermagem 70,91% em intervenções de cuidados diretos e 22,38% em indiretos, 2,05% em atividades associadas e 4,66% em pessoais ao trabalho. O domínio da taxonomia da NIC, de maior representatividade para a equipe de enfermagem, foi o Fisiológico Complexo (61,68%), com a intervenção Assistência Cirúrgica (30,62%), a mais frequente. No período de estudo, foram realizadas 85 cirurgias, com o maior movimento cirúrgico de porte I (34,12%); tempo médio do intraoperatório de 218,10min; tempo médio para o intervalo de substituição de cirurgia de 48,12min, correspondendo ao tempo médio de limpeza e reabastecimento da SO de 33,81min e ao tempo médio de espera de 14,31min. A taxa de ocupação do CC foi de 78,57% e a quantidade de SO foi adequada para o atendimento de cirurgias eletivas e urgência/emergência e encaixes. O enfermeiro participa 18,38% e os técnicos de enfermagem 81,62% da carga de trabalho. A produtividade da equipe de enfermagem atingiu 95,34%, considerada alta, com base nos dados preconizados na literatura. A análise dos indicadores intervenientes no dimensionamento de profissionais de enfermagem do CC possibilitou reformular a equação proposta por Possari (2001) e obter valores mais próximos à realidade do CC. O conhecimento da carga de trabalho, no que se refere à identificação das intervenções/atividades realizadas pela equipe de enfermagem, poderá contribuir na argumentação efetiva de um quadro de profissionais adequado às necessidades de cuidado, no período transoperatório, que proporcione segurança ao paciente e à equipe de enfermagem que o assiste.
In order to analyze indicators involved in nursing staff for assistance during the perioperative period of a Specialized Oncology Surgical Center (SC), this observational, transverse and descriptive case study was carried out in a quantitative method. The methodology included: identification of activities by means of written records and observation of activities performed by nursing staff; mapping activities in standardized language of nursing interventions according to Nursing Interventions Classification (NIC), validation of interventions / nursing activities using the workshop technique , measuring time spent on interventions / nursing activities adopting the work-sampling technique and identifying indicators for the calculation of nursing staff. Forty-nine nursing interventions, seven domains and 20 classes were identified and validated, according to NIC taxonomy. We obtained 4831 measurements of interventions / activities performed by nursing staff, in the perioperative period, at the SC. Time spent by the professionals were as follows: nurses 42.79% of their time in direct care interventions and 42.00% in indirect, 8.00% on personal activities and 7.21% in work-related activities; nursing technicians (Room Operating Circulation - ROC) 64.27% in direct care interventions and 30.46% in indirect activities, 0.45% in associated activities and 4.82% on personal activities; nursing technicians (Instrumented surgery - IS) 94.85% in direct care interventions and 2.20% indirect and 2.95% on personal activities; nursing technicians (Patient Reception area- PR) 57.08% in direct care interventions and 28.75% indirect, 7.92 % in associated activities and 6.25% on personal activities and nursing staff 70.91% in direct care interventions and 22.38% indirect , 2.05% in associated activities and 4.66% on personal related-work. The most representative NIC taxonomy domain for the nursing staff was the Physiological Complex (61.68%), being the Surgical Assistance intervention (30.62%) the most frequent. During the study 85 surgeries were performed, with predominance of surgeries of major size procedures (34.12%), mean time of intraoperative 218.10 min, mean time interval for replacement surgery of 48.12 min, corresponding to the mean time for cleaning and refilling the OR of 33.81 min and the mean time of waiting 14.31 min. The occupancy rate of SC was 78.57% and the number of OR was adequate for the assistance of elective and urgent/emergency and optional surgeries. The nurse participates 18.38% of the workload and nursing technicians 81.62%. The nursing staff productivity reached 95.34%, considered high when compared to data recommended in the literature. The analysis of the intervenient indicators involved in nursing staff on SC allowed to reformulate the equation proposed by Possari (2001) and to obtain values closer to the reality of SC. Knowledge of the workload with regard to identification of interventions / activities performed by nursing staff may help in effective reasoning about a professional staff appropriate to the needs of care during perioperative period, providing safety for patient and nursing staff.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Valente, Catarina Beatriz Ribeiro. „Cuidados nutricionais centrados no doente em oncologia“. Bachelor's thesis, [s.n.], 2018. http://hdl.handle.net/10284/7550.

Der volle Inhalt der Quelle

Annotation:

Trabalho Complementar apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de licenciada em Ciências da Nutrição
Objetivo: Neste artigo pretendemos fazer uma revisão da literatura sobre Cuidados nutricionais centrados no doente em oncologia e compreender o papel do Nutricionista no âmbito dos cuidados centrados no doente oncológico, particularmente a dimensão da sua intervenção. Metodologia: Revisão da literatura sobre cuidados nutricionais centrados no doente em oncologia, com particular atenção no papel do nutricionista como elo de ligação entre doente/familiares e restantes membros da equipa de saúde multidisciplinar em oncologia. Realizaram-se pesquisas na PubMed, Scielo, Institute for Healthcare Improvement e The Oncologist. Resultados: A maioria das publicações é relativa aos últimos 10 anos. Do total de 70 artigos encontrados foram selecionados 23. Da pesquisa realizada é possível deduzir que há falta de dados sobre o papel do Nutricionista como elemento integrante da equipa multidisciplinar, em cuidados oncológicos. Conclusão: Conclui-se que o nutricionista, sobretudo neste contexto, tem um papel chave, sendo ele o porta voz do mundo do doente, sendo que a nutrição pode ser um suporte adjuvante a outras terapias. O nutricionista é uma mais valia no processo de cuidar o doente, através da implementação de rotinas de avaliação, intervenção nutricional, melhor comunicação entre o doente-família-equipa multidisciplinar.
Objective: In this article we intend to review the literature on nutritional care centered on the patient in oncology and to understand the role of the nutritionist in this type of care, particularly the dimension of his intervention. Methodology: Review of the literature on nutritional care centered on the patient in oncology, paying particular attention to the role of the nutritionist as the link between the patient / family and the other members of the multidisciplinary health team in oncology. Research was done at PubMed, Scielo, Institute for Healthcare Improvement and The Oncologist. Results: Most publications refer to the last 10 years. From the total of 70 articles found, 23 were selected. From the research conducted it is possible to deduce that there is a lack of data on the role of the nutritionist, as an integral element of the multidisciplinary team in Oncology Care. Conclusion: We can conclude that the nutritionist, especially in this context, plays a key role, being the advocate of the world of the patient, and that nutrition can be a support to other therapies. The nutritionist is an asset in the process of caring for the patient, through the implementation of evaluation routines, nutritional intervention, better communication between the patient-family-multidisciplinary team.
N/A

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Bücher zum Thema "Oncology center"

Joseph, Torkildson, Agrawal Anurag Kishor und Children's Hospital Medical Center (Oakland, Calif.), Hrsg. Handbook of pediatric hematology and oncology: Children's Hospital & Research Center Oakland. 2. Aufl. Chichester, West Sussex: Wiley-Blackwell, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Making cancer history: Disease and discovery at the University of Texas M.D. Anderson Cancer Center. Baltimore: Johns Hopkins University Press, 2008.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

International Conference on Dose, Time, and Fractionation. (2nd 1984 Madison, Wisc.). Optimization of cancer radiotherapy: Proceedings of the Second International Conference on Dose, Time and Fractionation in Radiation Oncology, September 12-14, 1984, Wisconsin Center, Madison, Wisconsin 53706. New York, N.Y: American Institute of Physics for the American Association of Physicists in Medicine, 1985.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Biggart, M. Gaile. A better deal for cancer patients: What the Northern Ireland Centre for Clinical Oncology has to learn. [s.l: The Author], 1998.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Meeting, British Association for Cancer Research. British Association for Cancer Research 36th annual meeting, jointly with Association of Cancer Physicians 10th annual meeting: The East Midlands Conference Centre, University of Nottingham, 2nd-5th April 1995. Houndmills, Basingstoke, UK: Scientific and Medical Division of Macmillan Press, 1995.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bignold, Leon P. David Paul von Hansemann: Contributions to oncology. Basel: Birkhäuser, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

British Association for Cancer Research. Meeting. British Association for Cancer Research 37th annual meeting, jointly with European Association for Cancer Research 14th meeting and Association of Cancer Physicians 11th annual meeting: Edinburgh Conference Centre, Heriot-Watt University, 31st March-3rd April 1996. Houndmills, Basingstoke: Stockton Press, 1996.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Course in Urological Oncology (6th 1990 Erice, Italy). Urological oncology: Reconstructive surgery, organ conservation, and restoration of function : proceedings of the Sixth Course in Urological Oncology, held at Ettore Majurana Centre, Erice, Sicily, Italy, March 25-31, 1990. Herausgegeben von Smith P. H, Pavone-Macaluso Michele und European Organization for Research on Treatment of Cancer. Genito-Urinary Tract Cancer Cooperative Group. New York, NY: Wiley-Liss, 1991.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

H, Smith P., und Pavone-Macaluso Michele, Hrsg. Urological oncology: Reconstructive surgery, organ conservation, and restoration of function : proceedings of the Sixth Course in Urological Oncology, held at Ettore Majorana Centre, Erice, Sicily, Italy, March 25-31, 1990. New York: Wiley-Liss, 1991.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Papini, Massimo, Hrsg. L'ultima cura. Florence: Firenze University Press, 2010. http://dx.doi.org/10.36253/978-88-8453-457-6.

Der volle Inhalt der Quelle

Annotation:

This book is the outcome of a new method of investigating the life experiences of health personnel engaged in paediatric oncology. It brings together the results of individual interviews with each member of the medical, nursing and technical staff in the Paediatric Oncology Department of the University Polyclinic of Padua and the Giannina Gaslini Institute of Genoa. The interviews, prepared using an open questionnaire format, were carried out by qualified personnel, after which the results were analysed and illustrated to the group of health care professionals involved. The two experiences, which are extremely significant in view of the distinction of the two centres of excellence involved, are compared and discussed with a view to making an interesting contribution to the debate on the delicate issues of bioethics implicated in problems connected with the end of life during the developmental stage.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Buchteile zum Thema "Oncology center"

Spikolavas, V., K. Valuckas, V. Atkocius, A. Mudenas, V. Cepulis, E. Drulia und R. Mickevicius. „IORT in a Lithuanian Oncology Center“. In Frontiers of Radiation Therapy and Oncology, 84–86. Basel: KARGER, 1997. http://dx.doi.org/10.1159/000061151.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Zampieri, P., G. B. Soattin, R. Faggin, P. L. Longatti, M. Gerosa, C. Licata, L. Casentini, V. Fornezza, A. Agostini und S. Mingrino. „Epidemiology of Primary Cerebral Tumors, Results of a Multi-Center Study in the Veneto Region of Northern Italy“. In Neuro-Oncology, 117–20. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3152-0_21.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Hong, David S., Kathrina L. Marcelo-Lewis und Patricia LoRusso. „Practicalities of Setting Up a Phase I Clinical Trial Unit Within an Academic Center“. In Phase I Oncology Drug Development, 71–83. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47682-3_4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ould Mohamed Yeslem, Ahmed El Mouna, Moussa Ould Cheibetta, Jilali Ghassoun, Oum Keltoum Hakam, Slimane Semghouli und Abdelmajid Choukri. „Quality Control Results for Linear Accelerator at Oncology Center in Nouakchott“. In Innovations in Smart Cities and Applications, 759–65. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-74500-8_69.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Yahalom, Joachim, und Subhash Gulati. „Autologous bone marrow transplantation for refractory or relapsed Hodgkin’s disease: The Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation“. In Annals of Oncology, 67–71. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-7305-4_11.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mendenhall, Nancy P., Kathryn E. Hitchcock und Jonathan D. Licht. „Successful Strategies to Exploit the Intersection Between the Radiation Oncology Department and the Cancer Center“. In Career Development in Academic Radiation Oncology, 327–41. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-71855-8_24.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mello, Josiane, und Angel Freddy Godoy Viera. „Proposal of Model for Curation Digital Objects of an Oncology Research Center“. In Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, 235–49. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-50072-6_18.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Suit, Herman D., und Jay S. Loeffler. „The New Optimism After WWII and the Decision for a Cancer Center at MGH 1945–1970“. In Evolution of Radiation Oncology at Massachusetts General Hospital, 29–42. Boston, MA: Springer US, 2010. http://dx.doi.org/10.1007/978-1-4419-6744-2_3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Perkins, Randa M., und Joseph Markowitz. „Development and Optimization of Clinical Informatics Infrastructure to Support Bioinformatics at an Oncology Center“. In Methods in Molecular Biology, 1–19. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0849-4_1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Malkin, M. G. „Interstitial Brachytherapy of Malignant Gliomas: The Memorial Sloan-Kettering Cancer Center Experience“. In Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors, 117–25. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-85039-4_12.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Oncology center"

Otoo, Mary A., Michelle Uriostigue Preza, Margaret Gavor, Darlene Kitterman und Oana Danciu. „Abstract 4764: An analysis of factors associated with oncology clinical trial activation at University of Illinois Cancer Center Oncology Clinical Trials Office“. In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-4764.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Starova, Olga Valeryevna, Yulia Valeryevna Batukhtina und Darya Igorevna Fedotova. „Financing drug purchase for the Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovskiy“. In International Scientific and Practical Conference. TSNS Interaktiv Plus, 2017. http://dx.doi.org/10.21661/r-462060.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Penteado, Nestor, Ubirajara Ferreira und Wagner Matheus. „Epidemiological profile and therapeutic approaches of bladder cancer patients referred to tertiary uro-oncology center“. In Congresso de Iniciação Científica UNICAMP. Universidade Estadual de Campinas, 2019. http://dx.doi.org/10.20396/revpibic2720192986.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Sidoruk, A., I. Berlev, A. Urmancheeva, N. Mikaya, N. Bondarev, E. Ulrikh, E. Nekrasova, T. Gorodnova, T. Rogovskaya und K. Kotiv. „EP421 The experience of the N.N. Petrov national research center of oncology in performing radical trachelectomy“. In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.480.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

De Jesús, M., F. E. Trujillo-Zamudio, Maria-Ester Brandan, Flora Herrera-Martinez, Veronica Ramírez-R. und Mercedes Rodriguez-Villafuerte. „Radiotherapy and Nuclear Medicine Project for an Integral Oncology Center at the Oaxaca High Specialization Regional Hospital“. In ELEVENTH MEXICAN SYMPOSIUM ON MEDICAL PHYSICS. AIP, 2010. http://dx.doi.org/10.1063/1.3531606.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Keller, Rachel B., Tali Mazor, Marios Giannakis, Jonathan Nowak, Lynette Sholl, Andrew Aguirre, Adam Bass et al. „Abstract C130: Precision oncology decision support within the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute (GI TARGET)“. In Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; October 26-30, 2019; Boston, MA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1535-7163.targ-19-c130.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gopan, Gayatri, Geetha Narayanan, Sreejith G. Nair, Prakash Purushothaman, Rona Joseph, Rekha A. Nair und Jagathnath Krishna. „Outcome of Treatment in Elderly Myeloma—A Single-Centre Experience“. In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735368.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction Multiple myeloma (MM) accounts for approximately 1% of all cancers and 10% of all hematologic malignancies. In our institution, we see around 200 patients with myeloma every year. We present our experience with multiple myeloma in the patients aged more than 60 years. Objectives This is a retrospective study of 300 newly diagnosed multiple myeloma patients above 60 years of age treated in the Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India, during the period between 2014 and 2017. The medical records of the patients were studied and following data were collected: demographic and clinical details, diagnostic and staging workup, primary treatment, response assessment, relapse, and survival. Survival was estimated using the Kaplan–Meier method. Results A total of 300 patients were included in the study. The median age was 66 years with a male-to-female ratio of 1.4:1. The common clinical presentations were backache (134), fatigue (49), lower respiratory infection (20), and paraparesis (14). Monoclonal protein was immunoglobulin (Ig)-G in 199 patients (66.6%), IgA in 52 patients (17.4%), IgM in 2 patients, and IgD in 1 patient. Light-chain disease was seen in 42 patients (14%). One hundred and sixty patients (53.5%) had ISS stage III. Only 285 patients received treatment, of which 203 (67.8%) received bortezomib-based regimen, - bortezomib and dexamethasone (BD; 33.4%); bortezomib, lenalidomide, and dexamethasone (BLD; 19.7%); bortezomib, cyclophosphamide, and dexamethasone (VCD; 8.7%); bortezomib, thalidomide, and dexamethasone (BTD; 2.3%); and bortezomib, melphalan, and prednisolone (3.7%). Nonbortezomib-based regimens used were melphalan and prednisolone (MP) alone or with thalidomide or lenalidomide (15%), lenalidomide and dexamethasone (LD; 10.4%), and thalidomide and dexamethasone (TD; 2%). Response assessment was done as per IMWG guidelines. Fifty-seven (26.3%) patients achieved complete response (CR), 94 (43.3%) achieved very good partial response (VGPR), 19 (8.8%) attained partial response (PR), 15 (5.6%) had stable disease, and 46 (15.4%) developed progressive disease. With bortezomib-based regimens, 119 patients (58.3%) achieved CR/VGPR, and with non-bortezomib based regimens, 42 patients (51.2%) achieved CR/VGPR. One hundred and forty-three patients (47.8%) received maintenance therapy of which 79 received maintenance with bortezomib, 49 with lenalidomide, and 15 with thalidomide. The average duration of maintenance was 24 months. Second-line chemotherapy regimens were used in 37 patients. Agents used were MP, LD, TD, and VCD. With second-line treatment, 15 patients achieved VGPR, 10 patients achieved partial response, and 25 patients developed progressive disease. Third-line chemotherapy regimens were used in 22 patients and the regimens used were pomalidomide and dexamethasone, MP, TD, LD, vincristine, doxorubicin, and dexamethasone and carfilzomib and dexamethasone. At a median follow-up of 34 months, the 2-year overall survival (OS) was 68%. The median progression-free survival was 21 months. The 2-year OS for patients receiving initial bortezomib-based regimen was 67.8% and non-bortezomib based regimen was 68% which was similar. Conclusion In this study, CR/VGPR rates and 2-year OS in patients treated with bortezomib and non-bortezomib based regimens were not statistically significant.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Vertinskiy, Andrey V., Leonid G. Sukhikh, Evgeniia S. Sukhikh und Yana N. Sutygina. „FIRST RESULTS AND ASPECTS OF IN VIVO DOSIMETRY SYSTEM IMPLEMENTATION OF EXTERNAL RADIATION THERAPY IN TOMSK REGIONAL ONCOLOGY CENTER“. In RAP Conference. Sievert Association, 2020. http://dx.doi.org/10.37392/rapproc.2019.37.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mason, Nicola, Christina Bailey, Erin Piazza, Alexander F. Haake, Achim D. Gruber, Cheryl London, M. R. Chambers et al. „Abstract 1693: Multi-national, multi-center collaboration to develop a novel gene expression tool for comparative translational immuno-oncology“. In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1693.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gustafson, Daniel L., Jared S. Fowles, Douglas H. Thamm, Rodney L. Page und Dawn L. Duval. „Abstract 5136: The Flint Animal Cancer Center (FACC) canine tumor cell line panel: A resource for comparative and translational oncology“. In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5136.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Oncology center"

Kraft, Andrew S. Oncology Center. Office of Scientific and Technical Information (OSTI), September 2009. http://dx.doi.org/10.2172/964284.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Scholle, Sarah, Suzanne Morton, Daren Anderson, David Kendrick, Juell Homco, Kristin Rodriguez, Rachelle Jean-Paul et al. Evaluating a New Patient-Centered Approach for Cancer Care in Oncology Offices. Patient-Centered Outcomes Research Institute® (PCORI), Januar 2020. http://dx.doi.org/10.25302/1.2020.ih.12114383.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!